Literature DB >> 20826216

Functional comparison of recombinant acidic mammalian chitinase with enzyme from murine bronchoalveolar lavage.

Eric R Goedken1, Robert F O'Brien, Tao Xiang, David L Banach, Susan C Marchie, Eve H Barlow, Stacy Hubbard, John A Mankovich, Jianjun Jiang, Paul L Richardson, Carolyn A Cuff, Andrew D Cherniack.   

Abstract

Acidic mammalian chitinase (AMCase) is an enzyme that selectively degrades the biopolymer chitin. Several chitinase enzymes are utilized by mammals to hydrolyze chitin encountered by inhalation and ingestion. AMCase is distinct from other mammalian chitinases as its activity is retained in strongly acidic conditions (pH <2.0). AMCase expression is induced by antigen-induced mouse models of allergic lung inflammation. This protein has also been implicated in the pathogenesis of asthma although its precise role is poorly defined. We describe a novel way to express and purify active murine AMCase. This material retains properties observed in mouse bronchoalveolar lavage (BAL) fluid with regard to pH preference of activity and its inhibition by cyclic peptide inhibitors argifin and argadin. We found that chitinase in BAL from both antigen-challenged and control animals have similar properties in this regard. This strongly supports the notion the same enzyme (AMCase) gives rise to chitinase activity in both challenged and unchallenged animals. We also describe expression of active human AMCase. The methods described in this paper provide a reliable source of recombinant AMCase that can be utilized to expand understanding of AMCase's role in regulating allergic inflammation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826216     DOI: 10.1016/j.pep.2010.08.013

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  6 in total

1.  Acidic Mammalian chitinase and the eye: implications for ocular inflammatory diseases.

Authors:  Claudio Bucolo; Maria Musumeci; Salvatore Musumeci; Filippo Drago
Journal:  Front Pharmacol       Date:  2011-07-25       Impact factor: 5.810

2.  Loss and Gain of Human Acidic Mammalian Chitinase Activity by Nonsynonymous SNPs.

Authors:  Kazuaki Okawa; Misa Ohno; Akinori Kashimura; Masahiro Kimura; Yuki Kobayashi; Masayoshi Sakaguchi; Yasusato Sugahara; Minori Kamaya; Yoshihiro Kino; Peter O Bauer; Fumitaka Oyama
Journal:  Mol Biol Evol       Date:  2016-10-04       Impact factor: 16.240

3.  RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study.

Authors:  Catherine S Tripp; Carolyn Cuff; Andrew L Campbell; Barbara A Hendrickson; Jeff Voss; Terry Melim; Chengbin Wu; Andrew D Cherniack; Kenneth Kim
Journal:  Adv Ther       Date:  2017-04-28       Impact factor: 3.845

Review 4.  Chitins and chitinase activity in airway diseases.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  J Allergy Clin Immunol       Date:  2018-06-28       Impact factor: 10.793

5.  Spontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease.

Authors:  Steven J Van Dyken; Hong-Erh Liang; Ram P Naikawadi; Prescott G Woodruff; Paul J Wolters; David J Erle; Richard M Locksley
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

6.  Protein A-mouse acidic mammalian chitinase-V5-His expressed in periplasmic space of Escherichia coli possesses chitinase functions comparable to CHO-expressed protein.

Authors:  Akinori Kashimura; Kazuaki Okawa; Kotarou Ishikawa; Yuta Kida; Kokoro Iwabuchi; Yudai Matsushima; Masayoshi Sakaguchi; Yasusato Sugahara; Fumitaka Oyama
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.